Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Caucaseco Scientific Research Consortium is a prominent biomedical research organization based in Cali, Colombia, specializing in the study and prevention of tropical diseases. The center is globally recognized for its expertise in malaria research, particularly focusing on the development and clinical evaluation of vaccines against Plasmodium vivax. Caucaseco operates integrated facilities that include basic science laboratories, insectaries, and clinical trial units capable of conducting Phase 1 and Phase 2 studies. Through long-standing collaborations with international entities like the National Institutes of Health (NIH) and the Bill & Melinda Gates Foundation, the consortium plays a critical role in advancing global health initiatives. Their work encompasses immunology, epidemiology, and the development of diagnostic tools tailored for endemic regions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Caucaseco Scientific Research Consortium.